Liftstream is an executive search recruitment company in the life sciences sector
Fidelity Biosciences and REGENX launch new gene therapy company
Authored by James Sheppard
Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business
Tagged AAV, Allan M. Fox, Ben Auspitz, deno-associated virus, Dimension Therapeutics, Donald J. Hayden, Emil Kakkis, Fidelity Biosciences, FOXKISER, Gene therapy, genetic disease, Genzyme, hemophilia, investors, James Wilson, REGENX, Sam Wandsworth, series A funding, Thomas R. Beck, Ultragenyx, venture capital
Leave a comment